Drug Manufacturers - General Industry Stocks
The Drug Manufacturers - General industry currently includes 16 publicly traded companies in the StockSifting database and sits within Healthcare. Reviewing company descriptions in this group highlights recurring themes such as Essence, Organization, Treatment, Delivers, Treat. Names like Eli Lilly and Company, AbbVie Inc., AstraZeneca PLC, and Novartis AG illustrate how businesses in this industry may compete through scale, specialization, pricing power, technology, distribution, or customer relationships. For US investors, this industry view is useful for comparing valuation multiples, profitability, dividends, return ratios, and 52-week price ranges across similar businesses instead of mixing unrelated peers. Use the table below to screen the full list, compare fundamentals, and narrow down which stocks merit further research.
About the Drug Manufacturers - General industry
This Drug Manufacturers - General industry page is designed for US investors who want a cleaner peer comparison set. Instead of screening unrelated stocks together, you can review businesses from the same industry, compare valuation and profitability, and move into individual company pages for deeper research.
16 Companies in Drug Manufacturers - General
Compare US-listed companies by price, P/E ratio, market cap, dividend yield, ROCE, ROE, and 52-week high-low range.
| S.No.↑ | Company Name↕ | Price↕ | P/E↕ | Market Cap↕ | Div Yield↕ | ROCE↕ | ROE↕ | 52 Week High↕ | 52 Week Low↕ |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $921 | 40.12 | $868.52 B | 0.75% | 38.44% | 1.01% | $1,133.95 | $623.78 |
| 2 | AbbVie Inc. | NOT FOUND | 86.59 | $360.82 B | 3.4% | 22.16% | 62.25% | $244.81 | $168.54 |
| 3 | AstraZeneca PLC | $196.47 | 30 | $305.64 B | 1.58% | 15.97% | 22.84% | $15,730 | $9,651 |
| 4 | Novartis AG | $147.76 | 20.66 | $301.93 B | 3.13% | 21.09% | 30.81% | $131 | $87.89 |
| 5 | Merck & Co., Inc. | $112.83 | 15.49 | $278.33 B | 2.9% | 20.37% | 36.88% | $125.14 | $73.31 |
| 6 | Amgen Inc. | $346.69 | 24.37 | $187.08 B | 2.84% | 13.95% | 1.06% | $391.29 | $261.43 |
| 7 | Gilead Sciences, Inc. | $133.45 | 19.68 | $165.41 B | 2.41% | 24.79% | 40.66% | $157.29 | $93.37 |
| 8 | Pfizer Inc. | $26.9 | 19.83 | $152.79 B | 6.25% | 10.17% | 8.89% | $28.75 | $21.87 |
| 9 | Novo Nordisk A/S | $39.12 | 10.82 | $131.02 B | 4.54% | 39.01% | 60.7% | $533.4 | $224.25 |
| 10 | Bristol-Myers Squibb Company | $59.38 | 17.16 | $121.36 B | 4.26% | 20.6% | 40.44% | $62.89 | $42.52 |
| 11 | Biogen Inc. | $191.44 | 21.83 | $28.09 B | — | 9.46% | 7.39% | $202.41 | $114.66 |
| 12 | Organon & Co. | $9.26 | 12.89 | $2.41 B | 0.86% | 11.7% | 30.56% | $13.24 | $5.69 |
| 13 | Scilex Holding Company | $6.95 | — | $58.97 M | — | 55.67% | 39.83% | $34.27 | $3.6 |
| 14 | MIRA Pharmaceuticals, Inc. | $1.12 | — | $47.06 M | — | -100.98% | -1.66% | $2.45 | $0.83 |
| 15 | Nasus Pharma Ltd. | $2.86 | — | $19.29 M | — | -172.62% | 2637.84% | $9.99 | $1.98 |
| 16 | Medicus Pharma Ltd. | $0.34 | — | $13.54 M | — | -27863.04% | -29.81% | $8.94 | $0.29 |